Ryan Specialty Q3 Revenue Up 4.7% but Organic Growth Slows to 4.0%; Guidance Trimmed
RYAN sits 48% above its 52-week low of $29.28.
Summary
Ryan Specialty's Q3 organic revenue growth fell to 4.0% from 15.0% a year ago, even as revenue rose 4.7% to $790.0M and adjusted diluted EPS climbed 8.5% to $0.51. The company held its mid-single-digit organic growth guide but now expects Adjusted EBITDAC margin down modestly for 2026.
Key Events · Earnings and Guidance · RYAN
-
Organic Growth Slows to 4.0%
Organic revenue growth decelerated to 4.0% in Q3 2026 from 15.0% a year ago — the sharpest slowdown in recent quarters — on total revenue of $790.0M (+4.7%).
-
Margins Slip, EPS Still Grows
Adjusted EBITDAC rose 3.8% to $244.4M but margin fell to 30.9% from 31.2%; adjusted diluted EPS rose 8.5% to $0.51 and net income jumped 40.6% to $88.0M.
-
Guidance: Margin Now Down Modestly
Full-year 2026 organic revenue growth is guided to mid-single digits, with Adjusted EBITDAC margin now expected down modestly versus the prior year.
-
Capital Return Continues
The company returned $173.7M in Q3 via $150.0M of buybacks (3.5M shares) and $23.7M of dividends/distributions; $150.0M remains on the repurchase authorization.
Analysis · RYAN · Finance
The headline is the organic growth collapse to 4.0% from 15.0% a year ago — the sharpest deceleration in recent memory for a company that has traded on premium growth multiples. Revenue of $790.0M (+4.7%) and adjusted EBITDAC of $244.4M (+3.8%) still grew, and adjusted diluted EPS rose 8.5% to $0.51, but the margin slipped to 30.9% from 31.2%. Management kept its mid-single-digit organic growth target for 2026 while now guiding Adjusted EBITDAC margin down modestly versus last year — a soft profit outlook layered on a growth slowdown. The $150.0M buyback authorization remaining and a $0.13 quarterly dividend show capital return continues, but they do not offset the growth reset.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RYAN was trading at $43.28 on NYSE in the Finance sector, with a market capitalization of approximately $11.1B. The 52-week trading range was $29.28 to $58.94. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.